Unknown

Dataset Information

Genetic evidence for amlodipine's protective role in gastroesophageal reflux disease: A focus on CACNB2.


ABSTRACT:

Objective

This study aims to elucidate the causal relationship between genetically predicted amlodipine use and the risk of gastroesophageal reflux disease (GERD) using a bidirectional Mendelian Randomization (MR) approach and to explore the underlying genetic and molecular mechanisms through functional enrichment analysis and the construction of a competing endogenous RNA (ceRNA) network.

Methods

Publicly available GWAS datasets from the Neale Lab consortium were used, including data on amlodipine (13,693 cases, 323,466 controls) and GERD (14,316 cases, 322,843 controls). Genome-wide significant SNPs were selected as instrumental variables and clustered by linkage disequilibrium. MR analysis was conducted using R software with all five methods. Sensitivity analyses assessed

SUBMITTER: Zhang L 

PROVIDER: S-EPMC11835245 | biostudies-literature | 2025

REPOSITORIES: biostudies-literature